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A B S T R A C T
Iodinated contrast media are of paramount importance in the field of modern inter-
ventional cardiology. Although iodinated contrast media have an overall good safety 
profile, severe or life-threatening reactions can also occur. Herein, we report the 
case of a 74-year-old female patient who presented with non-ST elevation myocardial 
infarction and underwent a successful percutaneous coronary intervention. Shortly 
after the procedure the patient developed the full-blown clinical picture of an iodi-
nated contrast media adverse reaction that was timely recognized and treated. The 
two types of adverse reactions to iodinated contrast media during a percutaneous 
coronary intervention are being discussed. A high level of clinical suspicion is war-
ranted to ensure prompt recognition and appropriate management.
I n T R o d u C T I o n
Organic radiographic iodinated contrast media (ICM) have been among the most 
commonly used agents in the modern era of medicine and have become of paramount 
importance in the field of interventional cardiology. Although ICM have a good safety 
record, with usually mild and self-limited adverse effects, severe or life-threatening 
reactions can also occur. Therefore, physicians should be able to immediately recognize 
and treat the severe reactions of ICM.1,2
C A S e  R e p o R T
We present the case of a 74-year-old female patient who was admitted to our 
cardiology department due to non-ST elevation myocardial infarction. She had a 
history of diabetes mellitus type II, arterial hypertension and hyperlipidemia and had 
recently developed angina and dyspnea. On admission, she complained of chest pain. 
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The electrocardiogram at admission revealed a normal sinus 
rhythm with ST depression (2.5mm) and negative T waves 
in the inferior leads. Her blood pressure and oxygen satura-
tion were within normal range. High-sensitivity troponin 
was elevated (164.0pg/ml, normal range 0-34.2pg/ml) and 
the patient was loaded with aspirin and ticagrelor and trans-
ferred to the Cath lab. She underwent coronary angiography 
via the transradial approach, which revealed a culprit lesion 
in the mid segment of the right coronary artery (RCA, 95% 
stenosis) (Figure 1A), and a stenotic lesion in the circumflex 
artery (LCx, 90% stenosis in the mid segment) (Figure 2A). 
Crossover to the femoral approach had to be undertaken 
because of anatomic variation of the brachial artery. Both le-
sions were successfully treated by deploying everolimus drug 
eluting stents (2.75×18mm at the RCA and 2.75×26mm at the 
LCx) establishing at the end a TIMI 3 flow (Figures 1B, 2B). 
At this point, the patient complained of dizziness and a metal-
lic taste in her mouth combined with sudden drop in systolic 
blood pressure (down to 55mmHg) and bradycardia (45bpm). 
Intravenous (IV) atropine was administered up to a total dose 
of 3 mg, however hypotension and bradycardia persisted. Due 
to the severity of what seemed to be a vasovagal reaction, we 
promptly reviewed our angiographic results to ensure that 
there was no complication and we administered IV dopamine 
(15mcg/kg/min) followed by epinephrine (1:10,000 solution, 
5mcg/min). The persistence of the reaction and the metallic 
taste guided our thought to a possible reaction to the contrast 
media. Epinephrine was up-titrated (to 15mcg/min), and 
125mg of hydrocortisone were also administered. Eventually, 
the patient was hemodynamically stabilized and transferred to 
our coronary care unit (CCU). In CCU, the patient’s condition 
deteriorated further; generalized edema developed and a drop 
in her hemoglobin of 4mg/dl occurred with no apparent hemor-
rhage. She received one unit of concentrated red blood cells. 
The next day a CT abdominal scan was performed excluding 
a retroperitoneal hematoma. During the exam we observed a 
sparkling appearance of the small intestine and the gallblad-
der, attributable to the ICM. The edema gradually subsided 
with diuresis. The patient was discharged 8 days later with 
no further complications and a hemoglobin value of 11mg/dl 
(admission value 12mg/dl).
d I S C u S S I o n
Adverse reactions to ICM are classified as idiosyncratic 
(also termed anaphylactoid) and non-idiosyncratic (also 
termed non-anaphylactoid or physiochemotoxic).3 Idiosyn-
cratic reactions typically occur within 20 minutes after the 
ICM injection, are dose-independent, have the same mani-
festations as anaphylactic reactions and can be classified as 
mild, moderate, and severe. Non-idiosyncratic reactions, on 
the other hand, cover a spectrum of cardiovascular reactions, 
such as bradycardia, low blood pressure, vasovagal reactions, 
arrhythmias or ischemia, and extend to non-cardiac manifesta-
tions, i.e. neuropathy, extravasation, nausea, and vomiting as 
well as delayed reactions.4,5 Sensation of warmth and a metallic 
taste in mouth are indications of a non-idiosyncratic reaction 
to the contrast media. 
Non-idiosyncratic cardiovascular reactions during a percu-
taneous coronary intervention (PCI) can be misinterpreted as 
a complication of the procedure per se or as a simple vasovagal 
reaction. Persistence of the symptoms, even though the pro-
cedure has been successfully completed, can be an alarming 
sign of an ICM adverse reaction.6 Our patient developed a 
non-idiosyncratic reaction to ICM, manifested as a severe 
vasovagal reaction escalating to shock, generalized edema, 
and anemia. To our knowledge this is a rare report of a non-
idiosyncratic reaction to ICM after a PCI.
Non-idiosyncratic reactions can manifest in various 
ways. ICM exerts a direct negative inotropic effect on the 
myocardium and can precipitate bradycardia and peripheral 
vasodilatation. Autonomic manifestations, such as nausea, 
vomiting, and diaphoresis, or mental status changes may also 
occur.3 Untreated, these effects can lead to cardiovascular 
FIguRe 1. A: Coronary angiography of the RCA (left projec-
tion). B: RCA after stent deployment. RCA: Right coronary 
artery.
FIguRe 2. A: Coronary angiography of the LCx (right caudal 
projection). B: LCx after stent deployment. LCx: Left circumflex 
artery.
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collapse and death. Moreover, ICM can lower the threshold 
of ventricular arrhythmias and induce cardiac arrhythmias, 
provoke fluid shifts leading to an intravascular hypervolemic 
status and pulmonary edema, precipitate angina or lead to 
Kounis syndrome.5 
The similarity of the cardiovascular and anaphylactic re-
actions to ICM can create perplexity in recognizing the true 
nature and severity of an adverse reaction, thus, leading to 
overtreatment or undertreatment of symptoms.2-4 The aim of 
our case is to point out that ICM adverse reactions during a 
PCI, particularly non-idiosyncratic ones, are extremely rare 
and can go undetected or be misidentified as PCI related 
complications.6 Physicians should keep in mind that what 
manifests as a simple vasovagal reaction can be a reaction to 
the contrast media, with prolonged hemodynamic compromise. 
On the other hand, acute hypotension or even shock is not 
always a complication of the PCI per se, but the cause may 
well be the contrast media. Therefore, familiarization with the 
presenting symptoms of ICM adverse reactions, vigilance, and 
prompt management are required.
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